Abstract
The composition of acrylic bone cement has been identified as one of the important parameters affecting its mechanical properties and may, in turn, ultimately influence the longevity of a cemented arthroplasty. Our aim in this study was to determine the influence of change of one compositional variable, the activator, on the fatigue performance and fracture toughness of specimens of the fully cured cement. To that end, three sets of cements were prepared, containing either the conventional activator, 4‐N,N dimethyl p‐toluidine (DMPT), or novel ones that are tertiary amines based on long‐chain fatty acids, that is, 4‐N,N dimethylaminobenzyl oleate (DMAO) and 4‐N,N dimethylaminobenzyl laurate (DMAL). In the fatigue tests, the specimens were subjected to tension–tension loading, and the results (number of cycles to failure, N~f~) were analyzed using the linearized form of the three‐parameter Weibull equation. The fracture toughness (K~Ic~) tests were conducted with rectangular compact tension specimens. All fracture surfaces were subsequently examined with scanning electron microscopy. We found that the Weibull mean fatigue lives for specimens fabricated using the DMPT, DMAL, and DMAO containing cements were 272,823, 453,551, and 583,396 cycles, respectively. The corresponding values for K~Ic~ were 1.94 ± 0.05, 2.06 ± 0.09, and 2.00 ± 0.07 MPa√m, respectively. Statistical analyses showed that for both the DMAL‐ and DMAO‐containing cements, the mean values of N~f~ were significantly higher compared to the corresponding value for the DMPT‐containing cement (Mann–Whitney test; α < 0.10). This result is attributed to the higher molecular weights of the former cements compared to the latter. The same trend was found for the mean K~Ic~ values (Mann–Whitney test; α < 0.05), with the trend being explained in terms of the differences seen in the crack morphologies. These results thus demonstrate that these novel amines are viable alternatives to DMPT for incorporation into acrylic bone cement formulations in the future. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 67A: 571–577, 2003